HER2 positive metastatic breast cancer: What happens after first line failure?
For women with metastatic HER2 positive breast cancer, the introduction of trastuzumab into routine practice was transformative. More recently, the addition of pertuzumab has further improved the outlook. However in almost all cases, the disease unfortunately progresses. Much research has gone into...
| Main Author: | |
|---|---|
| Format: | Journal Article |
| Published: |
Cancer Council Australia
2016
|
| Online Access: | http://hdl.handle.net/20.500.11937/58480 |